Adipokines play a significant role in cardiometabolic diseases. Asprosin, a newly discovered
adipokine, was first identified as a glucose-raising protein hormone. Asprosin also …

White adipose tissue is a dynamic endocrine organ that releases an array of adipokines,
which play a key role in regulating metabolic homeostasis and multiple other physiological …

Asprosin is a recently discovered protein released during fasting conditions mainly by
adipocytes from white adipose tissue. As a glucogenic peptide, it stimulates the release of …

Obesity is an increasingly serious epidemic worldwide characterized by an increase in the
number and size of adipocytes. Adipose tissue maintains the balance between lipid storage …

Asprosin, a novel glucogenic adipokine, is encoded by two exons (exon 65 and exon 66) of
the gene Fibrillin 1 (FBN1) and mainly synthesized and released by white adipose tissue …

Background Asprosin has been identified as a novel hormone enriched in white adipose
tissue and is pathologically increased in insulin-resistant mice and humans. However …

Adipose tissue malfunction leads to altered adipokine secretion which might consequently
contribute to an array of metabolic diseases spectrum including obesity, diabetes mellitus …

Objective. Asprosin, a new adipocytokine, has reportedly been associated with glucose
release, dyslipidemia, and insulin resistance (IR). However, the relationship of asprosin with …

Background Asprosin, a newly identified adipokine, is pathologically increased in
individuals with insulin resistance. However, the available evidence on the association of …

Fibrillin is the major constituent of extracellular microfibrils, which are distributed throughout
connective tissues. Asprosin is derived from the C-terminal region of the FBN1 gene, which …